|
CASK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.614300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.040400E-02 |
| Normal-vs-Stage2 |
3.494400E-01 |
| Normal-vs-Stage3 |
6.485800E-02 |
| Normal-vs-Stage4 |
1.422550E-01 |
| Stage1-vs-Stage2 |
8.220000E-01 |
| Stage1-vs-Stage3 |
6.011800E-01 |
| Stage1-vs-Stage4 |
6.795600E-01 |
| Stage2-vs-Stage3 |
5.749800E-01 |
| Stage2-vs-Stage4 |
5.968600E-01 |
| Stage3-vs-Stage4 |
9.915000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.507730E-02 |
| Normal-vs-AfricanAmerican |
5.743200E-01 |
| Normal-vs-Asian |
5.530400E-01 |
| Caucasian-vs-AfricanAmerican |
5.927200E-01 |
| Caucasian-vs-Asian |
4.952600E-01 |
| AfricanAmerican-vs-Asian |
9.953000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.606000E-02 |
| Normal-vs-Female |
5.242000E-02 |
| Male-vs-Female |
6.639400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.368300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.472400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.721000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.111800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.244800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.356400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.383000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.051800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.518000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.109600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.371900E-02 |
| Classical-VS-Follicular |
2.322600E-01 |
| Classical-VS-Other |
4.524800E-01 |
| Classical-VS-Normal |
7.296100E-02 |
| Tall-VS-Follicular |
1.408100E-02 |
| Tall-VS-Other |
8.540200E-01 |
| Tall-VS-Normal |
4.620700E-03 |
| Follicular-VS-Other |
3.290400E-01 |
| Follicular-VS-Normal |
9.954400E-01 |
| Other-VS-Normal |
4.687900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.042000E-01 |
| Normal-vs-N1 |
1.251010E-01 |
| N0-vs-N1 |
4.413800E-01 |
|
|
